Skip to main content
An official website of the United States government

granisetron

View Patient Information
An indazole derivative with antiemetic properties. As a selective serotonin receptor antagonist, granisetron competitively blocks the action of serotonin at 5-hydroxytryptamine3 (5-HT3) receptors, resulting in the suppression of chemotherapy- and radiotherapy-induced nausea and vomiting.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
US brand name:Sancuso
Sustol
Chemical structure:1-methyl-N-(9-methyl-endo-9-azabicyclo(3.3.1)non-3-yl)-1H-indazole-3-carboxamide
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search